Haleon PLC (LSE:HLN, NYSE:HLN) steadied the ship last week for consumer staples suppliers after a results shock from Reckitt Benckiser, according to analysts at Barclays.
Indeed, Haleon is building a solid track record of organic growth and making rapid progress on deleverage and capital return, added the broker.
“Limited margin visibility is the only wrinkle, but with 62% gross margins we think continued OSG (organic sales growth) momentum means underlying profit (EBIT) margins will ultimately take care of themselves," said the broker.
Overweight with a price target of 390p is the bank’s investment view.
Shares were down 2.3% at 322.5p on Monday.